Cargando…
Chromosome 3p alterations in pancreatic endocrine neoplasia
Pancreatic endocrine tumors (PET) are rare neoplasms classified as functioning (F-PET) or non-functioning (NF-PET) according to the presence of a clinical syndrome due to hormonal hypersecretion. PETs show variable degrees of clinical aggressiveness and loss of chromosome 3p has been suggested to be...
Autores principales: | Amato, Eliana, Barbi, Stefano, Malpeli, Giorgio, Bersani, Samantha, Pelosi, Giuseppe, Capelli, Paola, Scarpa, Aldo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016198/ https://www.ncbi.nlm.nih.gov/pubmed/20981439 http://dx.doi.org/10.1007/s00428-010-1001-x |
Ejemplares similares
-
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes
por: Amato, Eliana, et al.
Publicado: (2016) -
Methylation-associated down-regulation of RASSF1A and up-regulation of RASSF1C in pancreatic endocrine tumors
por: Malpeli, Giorgio, et al.
Publicado: (2011) -
Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries
por: Corbo, V., et al.
Publicado: (2012) -
Reporting Tumor Molecular Heterogeneity in Histopathological Diagnosis
por: Mafficini, Andrea, et al.
Publicado: (2014) -
Surgical treatment of pancreatic endocrine tumors in multiple endocrine neoplasia type 1
por: Machado, Marcel Cerqueira Cesar
Publicado: (2012)